A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers
Owen, Ryan, Galanter, Joshua, Zhu, Rui, Cai, Fang, Tom, Jennifer, Wynne, Chris, Durk, Matthew, Chen, Liuxi, Kenny, Jane, She, Gaohong, Vadhavkar, Shweta, Hwang, Olivia, Chen, HubertVolume:
145
Langue:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2019.12.881
Date:
February, 2020
Fichier:
PDF, 102 KB
english, 2020